Back to search

Article

Preclinical Studies of Granulysin-Based Anti-Tn Immunotoxins as A New Antitumoral Treatment

2022-03-01

Abstract excerpt

Two granulysin (GRNLY) based immunotoxins were generated, one containing the scFv of the SM3 mAb (SM3GRNLY) and the other the scFv of the AR20.5 mAb (AR20.5GRNLY). These mAb recognize different amino acid sequences of aberrantly O-glycosilated MUC1, also known as the Tn antigen, expressed in a variety of tumor cell types. We first demonstrated the affinity of these immunotoxins for their antigen using surface plas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
817c5f2e-174d-56b3-b4f2-07cf37603ae5
DOI
10.20944/preprints202202.0268.v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preclinical Studies of Granulysin-Based Anti-Tn Immunotoxins as A New Antitumoral TreatmentDOI 10.20944/preprints202202.0268.v2
Select a neighboring publication to make it the new centre.